RNA - Company ID 0001599901
Avidity Biosciences, Inc. has filed 541 public company documents between 2014 and 2026. The most frequent type is insider trade (219 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 4 | Insider trade | 8mo ago2026-01-09 | 2026-01-07 | View filing |
| 4 | Insider trade | 8mo ago2026-01-09 | 2026-01-07 | View filing |
| 4 | Insider trade | 8mo ago2026-01-09 | 2026-01-07 | View filing |
| 4 | Insider trade | 8mo ago2026-01-09 | 2026-01-07 | View filing |
| 4 | Insider trade | 8mo ago2026-01-09 | 2026-01-07 | View filing |
| 4 | Insider trade | 8mo ago2026-01-09 | 2026-01-07 | View filing |
| PRER14A | PRER14A | 8mo ago2025-12-23 | - | View filing |
| 4 | Insider trade | 8mo ago2025-12-22 | 2025-12-19 | View filing |
| DEFA14A | Proxy materials | 8mo ago2025-12-22 | - | View filing |
| 4 | Insider trade | 8mo ago2025-12-19 | 2025-12-17 | View filing |
| 4 | Insider trade | 8mo ago2025-12-19 | 2025-12-17 | View filing |
| 4 | Insider trade | 8mo ago2025-12-19 | 2025-12-17 | View filing |
| 4 | Insider trade | 8mo ago2025-12-19 | 2025-12-17 | View filing |
| 4 | Insider trade | 8mo ago2025-12-19 | 2025-12-17 | View filing |
| 4 | Insider trade | 8mo ago2025-12-19 | 2025-12-17 | View filing |
| 4 | Insider trade | 8mo ago2025-12-19 | 2025-12-17 | View filing |
| DEFA14A | Proxy materials | 8mo ago2025-12-18 | - | View filing |
| 8-K | Major company event | 8mo ago2025-12-18 | 2025-12-14 | View filing |
| PRER14A | PRER14A | 9mo ago2025-12-12 | - | View filing |
| DEFA14A | Proxy materials | 9mo ago2025-12-08 | - | View filing |
| PREM14A | PREM14A | 9mo ago2025-11-24 | 2025-11-24 | View filing |
| DEFA14A | Proxy materials | 9mo ago2025-11-20 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 10mo ago2025-11-14 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 10mo ago2025-11-14 | - | View filing |
| 10-Q | Quarterly report | 10mo ago2025-11-10 | 2025-09-30 | View filing |
| 8-K | Major company event | 10mo ago2025-11-10 | 2025-11-10 | View filing |
| DEFA14A | Proxy materials | 10mo ago2025-11-10 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 10mo ago2025-11-07 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 10mo ago2025-11-05 | - | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 10mo ago2025-10-30 | - | View filing |
| SCHEDULE 13D/A | SCHEDULE 13D/A | 10mo ago2025-10-29 | - | View filing |
| DEFA14A | Proxy materials | 10mo ago2025-10-28 | - | View filing |
| DEFA14A | Proxy materials | 10mo ago2025-10-27 | - | View filing |
| DEFA14A | Proxy materials | 10mo ago2025-10-27 | - | View filing |
| DEFA14A | Proxy materials | 10mo ago2025-10-27 | - | View filing |
| 8-K | Major company event | 10mo ago2025-10-27 | 2025-10-25 | View filing |
| 4 | Insider trade | 10mo ago2025-10-24 | 2025-10-22 | View filing |
| SCHEDULE 13G/A | SCHEDULE 13G/A | 10mo ago2025-10-17 | - | View filing |
| 4 | Insider trade | 10mo ago2025-10-17 | 2025-10-15 | View filing |
| 8-K | Major company event | 11mo ago2025-10-14 | 2025-10-13 | View filing |
| 4 | Insider trade | 11mo ago2025-10-07 | 2025-10-03 | View filing |
| 4 | Insider trade | 11mo ago2025-09-23 | 2025-09-22 | View filing |
| 4 | Insider trade | 11mo ago2025-09-17 | 2025-09-15 | View filing |
| 4 | Insider trade | 11mo ago2025-09-17 | 2025-09-15 | View filing |
| 4 | Insider trade | 12mo ago2025-09-12 | 2025-09-11 | View filing |
| 8-K | Major company event | 12mo ago2025-09-12 | 2025-09-11 | View filing |
| 424B5 | Prospectus supplement | 12mo ago2025-09-12 | - | View filing |
| 144 | Insider sale notice | 12mo ago2025-09-11 | - | View filing |
| 8-K | Major company event | 1y ago2025-09-10 | 2025-09-09 | View filing |
| 424B5 | Prospectus supplement | 1y ago2025-09-10 | - | View filing |